*A 2019 British study published in The Lancet found that depressive symptoms were 5 percent lower after six weeks in a group treated with an SSRI, which offered, in the author’s words, “no convincing evidence” of an effect. After 12 weeks, there was a 13 percent reduction, a finding the researchers described as “weak.”